Back

Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During “J.P. Morgan Week 2021”

Read More

Back

Salarius Announces Exercise Of Warrants For $3.5 Million Of Gross Proceeds To Be Used For Ongoing Development Of Seclidemstat

Read More

Back

Salarius Pharmaceuticals Receives First Installment of $1.7 Million in Payments from the Cancer Prevention and Research Institute of Texas

Read More